纤维化间质性肺病低氧血症的发病率与预后意义:国际队列研究
该研究基于澳大利亚、加拿大和瑞士五个前瞻性ILD注册队列的848例纤维化ILD患者(其中258例IPF),估算运动性和静息性低氧血症的累积发病率,并评估其加入ILD-GAP模型后的附加预后价值。结果显示IPF患者低氧血症累积发病率显著更高,将低氧血症加入ILD-GAP模型可改善1年死亡和移植预测,扩展模型ILD-GAP-O2区分度更优。
要点
- IPF患者运动性和静息性低氧血症累积发病率均显著高于非IPF纤维化ILD患者。
- 运动性或静息性低氧血症加入ILD-GAP模型可显著改善1年死亡和移植预测。
- ILD-GAP-O2模型在验证队列中区分度优于原ILD-GAP模型且校准度相当。
核心结论
- IPF患者运动性和静息性低氧血症累积发病率高于非IPF纤维化ILD患者。
- 将低氧血症加入ILD-GAP模型形成的ILD-GAP-O2模型可为纤维化ILD的1年预后提供额外风险分层。
研究设计与样本
- 国际多中心前瞻性队列研究,纳入五个ILD注册队列共848例纤维化ILD患者,其中258例为IPF。
- 从诊断时起按1年间隔估算运动性和静息性低氧血症累积发病率,并校正死亡和肺移植竞争风险。
- 采用似然比检验评估低氧血症加入ILD-GAP模型对1年死亡或移植的预后意义,并分推导集和验证集评估扩展模型性能。
主要发现
- 运动性低氧血症1年、2年和5年总体累积发病率分别为6.1%、17.3%和40.1%。
- 静息性低氧血症1年、2年和5年总体累积发病率分别为2.4%、5.6%和16.5%。
- IPF患者运动性和静息性低氧血症累积发病率均显著高于非IPF患者(两者P < .001)。
- 运动性或静息性低氧血症加入ILD-GAP模型均改善1年死亡和移植预测(两者P < .001)。
- 验证队列中ILD-GAP-O2模型区分度C-index为0.80 vs 0.75,Akaike信息准则为400 vs 422,校准度相当。
临床怎么用
- 对纤维化ILD患者应关注运动性和静息性低氧血症的发生与进展。
- 可考虑在ILD-GAP模型基础上结合氧合状态(ILD-GAP-O2)进行1年预后风险分层。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hypoxemia is a cardinal feature of fibrotic interstitial lung disease (ILD). The incidence, progression, and prognostic significance of hypoxemia in patients with fibrotic ILD currently is unknown. RESEARCH QUESTION: What are the epidemiologic features of hypoxemia and its additive prognostic value in a current risk prediction model of fibrotic ILD? METHODS: We identified 848 patients with fibrotic ILD (258 with idiopathic pulmonary fibrosis [IPF]) in five prospective ILD registries from Australia, Canada, and Switzerland. Cumulative incidence of exertional and resting hypoxemia from the time of diagnosis was estimated at 1-year intervals in patients with baseline 6-min walk tests, adjusted for competing risks of death and lung transplantation. Likelihood ratio tests were used to determine the prognostic significance of exertional and resting hypoxemia for 1-year mortality or transplantation when added to the ILD-GAP model. The cohort was divided into derivation and validation subsets to evaluate performance characteristics of the extended model (the ILD-GAP-O2 model), which included oxygenation status as a predictor. RESULTS: The 1-, 2-, and 5-year overall cumulative incidence was 6.1%, 17.3%, and 40.1%, respectively, for exertional hypoxemia and 2.4%, 5.6%, and 16.5%, respectively, for resting hypoxemia, which were significantly higher in patients with IPF compared with patients without IPF (P < .001 for both). Addition of exertional or resting hypoxemia to the ILD-GAP model improved 1-year mortality and transplantation prediction (P < .001 for both). The ILD-GAP-O2 model showed improved discrimination (C-index, 0.80 vs 0.75) and model fit (Akaike information criteria, 400 vs 422) in the validation cohort, with comparable calibration. INTERPRETATION: Patients with IPF have higher cumulative incidence of exertional and resting hypoxemia than patients without IPF. The extended ILD-GAP-O2 model provides additional risk stratification for 1-year prognosis in fibrotic ILD.
引用
- Khor YH, Gutman L, Abu Hussein N, et al. Incidence and Prognostic Significance of Hypoxemia in Fibrotic Interstitial Lung Disease: An International Cohort Study. Chest. 2021. PMID: 33905679. doi:10.1016/j.chest.2021.04.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。